1-2 of 2
Jeremy S. Abramson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A prospective study of prophylactic dexamethasone with glofitamab in relapsed/refractory large B-cell lymphoma

Open Access
J. Erika Haydu, Matthew M. Lei, Robert A. Redd, Jeffrey A. Barnes, Elijah P. Darnell, Ephraim P. Hochberg, P. Connor Johnson, Ronald W. Takvorian, James I. Weitzman, Elliot C. Woods, Tiffany L. Hurvitz, Courtney D. Lafranchi, Patricia Livingstone, Julia M. Lynch, Emily N. Patterson, Jack E. Malespini, Brianne M. McGree, Alexa O. Santilli, Katherine A. Thorp, Maryanne M. Sherburne, Lindsey B. Wardrop, Uvette Y. Lou, Mark N. Sorial, Catherine Cho, Josie Ford, Ronnie Nemac, Jacob D. Soumerai, Jeremy S. Abramson
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (4): 100147.
https://doi.org/10.1016/j.bneo.2025.100147
Published: 2025
Journal Articles

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

Open Access
Reid W Merryman, Justin Kline, Robert A. Redd, Harrison Olszewski, Emma Welsh, Kathleen Pfaff, Hannah Lee, Mikaela McDonough, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D Jacobsen, Caron A. Jacobson, Austin I. Kim, Oreofe O. Odejide, Erin Michelle Parry, Christine E. Ryan, Margaret A. Shipp, Philippe Armand, Scott Rodig, Jeremy S. Abramson, Ann S. LaCasce
Journal: Blood Neoplasia
Blood Neoplasia 100173.
https://doi.org/10.1016/j.bneo.2025.100173
Published: 2025
Includes: Supplemental data